In breast cancer, miR-675-upregulated NEDD4L can catalyze the ubiquitination of PI3KCA, thereby inhibiting VEGFA secretion and ultimately inhibiting blood vessel formation (Guo X. Y. et al., 2022). Here, NEDD4L is linked to breast carcinoma.